Fig1 (Spironolactone Fig1)
Spironolactone Tablet
Product Images NDC 59651-428
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 59651-428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig2 (Spironolactone Fig2)
This text appears to be from a medical study, presenting data on various subgroups of patients with heart failure. The data includes demographic information such as age, gender, and race, as well as medical factors such as LVEF (Left Ventricular Ejection Fraction), diabetes, and kidney function. Medications such as digoxin and beta blockers are also mentioned. The results section includes comparisons of different treatments and their effects on heart failure.*
Package Label-principal Display Panel (25 mg (100 Tablets Bottle))
This is a description of a medication called Spironolactone USP 25mg manufactured by Aurobindo Pharma USA, Inc. Each tablet is accompanied by prescribing information and is meant to be dispensed in child-resistant containers. The recommended storage temperature is between 20-25°C, and the medication should be protected from light. There is some additional text that appears to be an overprinting zone coding area and is not readable.*
Package Label-principal Display Panel (50 mg (100 Tablets Bottle))
This is a description of Spironolactone Tablets, USP manufactured by Aurobindo Pharma USA, Inc. The package contains 100 tablets, each tablet containing Spironolactone USP 50 mg. The usual dosage should be observed according to the prescribing information. The tablets should be stored in a child-resistant, light-resistant container at a temperature of 20° to 25°C. The package is distributed under the NDC code 59651-427-01 and was made in India with the code TS/DRUGS/19/1993.*
Package Label-principal Display Panel (100 mg (100 Tablets Bottle))
Each tablet contains Spironolactone USP 100 mg. Usual dosage is to be seen in accompanying prescribing information. It is made in India and distributed by Aurobindo Pharma USA Inc. The tablets need to be dispensed in tight, light-resistant containers and stored at a temperature of 20° to 25°C (68° to 77°F) in order to protect from light. There is no further information available due to the limited text.*
Str1 (Spironolactone Str1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
